Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ectopic hormones as tumor markers.

W Z Borer

    Clinics in Laboratory Medicine
    |December 1, 1984
    PubMed
    Summary

    Certain cancers can produce peptide hormones, sometimes causing paraneoplastic syndromes. Measuring these hormones in blood can help monitor cancer activity and treatment effectiveness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Analbuminuric proteinuria: a true but transient finding.

    Clinical chemistry·1991
    Same author

    Differential expression of adenosine deaminase isozymes in acute leukemia.

    Blood·1988
    Same author

    Enzymatic differences between chronic lymphocytic leukemia and prolymphocytic leukemia.

    Leukemia research·1985
    Same author

    Optimizing reference values for the measurement of alpha 1-antitrypsin in serum: comparison of three methods.

    Clinical chemistry·1983
    Same author

    Autosomal or X-linked recessive syndrome of congenital lymphedema, hypoparathyroidism, nephropathy, prolapsing mitral valve, and brachytelephalangy.

    American journal of medical genetics·1983
    Same author

    Histochemical demonstration of terminal deoxynucleotidyl transferase in leukemia.

    Blood·1981

    Area of Science:

    • Endocrinology
    • Oncology
    • Biochemistry

    Background:

    • Some malignant tumors exhibit endocrine activity.
    • Tumor-secreted peptide hormones can elicit systemic effects.
    • Paraneoplastic syndromes arise from hormonal activity of cancers.

    Purpose of the Study:

    • To investigate the capacity of certain cancers to produce peptide hormones.
    • To explore the clinical relevance of hormone synthesis and secretion by tumors.
    • To assess the utility of plasma hormone measurement for monitoring cancer progression.

    Main Methods:

    • Review of literature on cancer endocrinology.
    • Analysis of case studies involving hormone-secreting tumors.
    • Discussion of diagnostic and monitoring applications of peptide hormone assays.

    Main Results:

    • Confirmed that specific cancers synthesize, store, and secrete peptide hormones.
    • Identified instances where secreted hormones cause clinically significant paraneoplastic syndromes.
    • Demonstrated the potential clinical utility of measuring plasma hormone levels for tumor monitoring.

    Conclusions:

    • Peptide hormone production by tumors is a recognized phenomenon.
    • Hormonal activity of cancers can manifest as paraneoplastic syndromes.
    • Plasma hormone level monitoring offers a valuable tool for assessing tumor activity in select cases.

    Related Experiment Videos